Literature DB >> 15616338

Influence of carbon dioxide on the MIC of telithromycin for Streptococcus pneumoniae: an in vitro-in vivo study.

Eric Batard1, Marie Emmanuelle Juvin, Cédric Jacqueline, Denis Bugnon, Jocelyne Caillon, Gilles Potel, Henri B Drugeon.   

Abstract

Incubation in CO(2) resulted in higher (> or =3 doubling dilution) MICs of telithromycin than those found in ambient air for 31.2% of 346 Streptococcus pneumoniae ermB-positive strains. An increased telithromycin MIC in CO(2) was not correlated with loss of its activity in the murine sepsis/peritonitis model.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15616338      PMCID： PMC538872          DOI： 10.1128/AAC.49.1.464-466.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents.

Authors:  M M Johnson; S L Hill; L J Piddock
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  Susceptibility of pneumococci to evernimicin: effect of CO2 and different methodologies.

Authors:  J M Hamilton-Miller; S Shah; D Loebenberg
Journal:  Clin Microbiol Infect       Date:  2001-06       Impact factor: 8.067

3.  Determination of minimum inhibitory concentrations.

Authors:  J M Andrews
Journal:  J Antimicrob Chemother       Date:  2001-07       Impact factor: 5.790

4.  Susceptibility testing of linezolid by two standard methods.

Authors:  J M Hamilton-Miller; S Shah
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-03       Impact factor: 3.267

5.  Influence of atmospheric conditions during incubation on the susceptibilities of Streptococcus pneumoniae isolates to five beta-lactam antibiotics.

Authors:  M Chomarat; L Chollet; M Peyret; J P Flandrois
Journal:  J Antimicrob Chemother       Date:  1997-10       Impact factor: 5.790

6.  Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin.

Authors:  M A Visalli; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

7.  In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.

Authors:  A B Brueggemann; K C Kugler; G V Doern
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

8.  In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors.

Authors:  P Bemer-Melchior; M E Juvin; S Tassin; A Bryskier; G C Schito; H B Drugeon
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

9.  High rate of erythromycin and clarithromycin resistance among Streptococcus pneumoniae isolates from blood cultures from Providence, R.I.

Authors:  J R Lonks; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

10.  Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.

Authors:  Fiona Walsh; Francis Carnegy; Joanne Willcock; Sebastian Amyes
Journal:  J Antimicrob Chemother       Date:  2004-03-31       Impact factor: 5.790
View more
  3 in total

1.  Emergence of a Streptococcus pneumoniae clinical isolate highly resistant to telithromycin and fluoroquinolones.

Authors:  Diego Faccone; Patricia Andres; Marcelo Galas; Marta Tokumoto; Adriana Rosato; Alejandra Corso
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

2.  Telithromycin-resistant Streptococcus pneumoniae.

Authors:  Fred Goldstein; Barbara Vidal; Marie D Kitzis
Journal:  Emerg Infect Dis       Date:  2005-09       Impact factor: 6.883

3.  In vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrations.

Authors:  Elena De Vecchi; Lucia Nicola; Monica Larosa; Lorenzo Drago
Journal:  BMC Microbiol       Date:  2008-01-29       Impact factor: 3.605
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.